Study of an Investigational Treatment with a Single Tablet that Includes a Combination of Multiple Medications for the Treatment of HIV

What we are studying

The purpose of this study is to show that a single tablet containing a combination of antiretrovirals for the treatment of HIV disease is comparable to a combination of another group of antiretrovirals for patients infected with HIV who have never been treated with antiretroviral treatment. The goal is to continue discovery of simplified HIV treatment options.

Who is Eligible

  • Genders:
    • Men
    • Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • HIV infection and ARV treatment-naïve
  • No prior use of any approved or experimental anti-HIV drug for any length of time

What is involved

  • Ekgs
  • Fasting blood draws
  • Physical exams
  • Vital signs
  • DXA scans
  • 12-13 visits during treatment

Compensation

$50 for each completed study visit

Contact Information

Study Coordinator
Lashaunda Holmes
Email
laholmes@wakehealth.edu
Phone
Not Listed

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.